Please assess the completion status of the following clinical trial:

Trial Title: Prospective Cohort of Kidney Transplanted Patients Receiving an Extended Releasing Tacrolimus-Everolimus Association

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients over 18 years old~* Patients informed and giving his agreement to the use of every collected data~* Patients with kidney transplantation for at least one year and being treated with the immunosppressive assiociation of Tacrolimus (Prograf ®)-Everolimus~* Patients whose investigators decides to switch from Prograf ® to an Envarsus ®-Everolimus association~Exclusion Criteria:~* Other transplantation~* Drug or alcohol abuse~* Patients unable to understand the purpose or modalities of this study, unable to give his agreement or unable to stick to the protocol~* Patients on an interventionnal protocol when included

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- TREVISE (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).